Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
McKinsey
Moodys
Harvard Business School
Johnson and Johnson

Last Updated: October 17, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GADOPENTETATE DIMEGLUMINE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Gadopentetate Dimeglumine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00004936 MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients Completed National Cancer Institute (NCI) N/A 2000-04-01 RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients.
NCT00004936 MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients Completed American College of Radiology Imaging Network N/A 2000-04-01 RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients.
NCT00033397 Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery Active, not recruiting National Cancer Institute (NCI) N/A 2002-02-01 RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women who are receiving chemotherapy before surgery for locally advanced breast cancer.
NCT00033397 Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery Active, not recruiting Alliance for Clinical Trials in Oncology N/A 2002-02-01 RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women who are receiving chemotherapy before surgery for locally advanced breast cancer.
NCT00310544 Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction Completed Bayer Phase 2 2006-03-01 The purpose of this study is to determine the dose of drug which is most effective in the delineation of dead heart muscle.
NCT00310596 Cardiovascular Safety Study of Magnevist® Injection at Two Dose Levels and Two Injection Rates in Normal Subjects Completed Bayer Phase 1 2004-01-01 The purpose of this study is to determine what effect Magnevist (gadopentetate dimeglumine) injection has on the way the heart conducts the electrical impulses that allow it to beat effectively. The study will compare Magnevist injection's effect to that of placebo (a saline injection).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Gadopentetate Dimeglumine

Condition Name

Condition Name for Gadopentetate Dimeglumine
Intervention Trials
Adult Anaplastic Oligodendroglioma 2
Adult Giant Cell Glioblastoma 2
Adult Anaplastic Ependymoma 2
Adult Anaplastic Astrocytoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Gadopentetate Dimeglumine
Intervention Trials
Oligodendroglioma 2
Gliosarcoma 2
Glioblastoma 2
Ependymoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Gadopentetate Dimeglumine

Trials by Country

Trials by Country for Gadopentetate Dimeglumine
Location Trials
United States 21
Argentina 1
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Gadopentetate Dimeglumine
Location Trials
California 5
Pennsylvania 2
North Carolina 2
New York 2
New Jersey 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Gadopentetate Dimeglumine

Clinical Trial Phase

Clinical Trial Phase for Gadopentetate Dimeglumine
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 2
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Gadopentetate Dimeglumine
Clinical Trial Phase Trials
Completed 8
Terminated 2
Withdrawn 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Gadopentetate Dimeglumine

Sponsor Name

Sponsor Name for Gadopentetate Dimeglumine
Sponsor Trials
National Cancer Institute (NCI) 4
Bayer 2
Bracco Diagnostics, Inc 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Gadopentetate Dimeglumine
Sponsor Trials
Other 11
Industry 5
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Moodys
Harvard Business School
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.